Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

China · Delayed Price · Currency is CNY

42.00

+0.44 (1.06%)

Jul 13, 2026, 3:00 PM CST

-39.81% (1Y)

Market Cap	8.12B -41.2%
Revenue (ttm)	1.52B +4.6%
Net Income	264.89M -29.9%
EPS	1.37 -31.3%
Shares Out	193.44M
PE Ratio	30.58
Forward PE	21.76
Dividend	0.32 (0.77%)
Ex-Dividend Date	Jun 22, 2026

Volume	3,727,646
Open	41.50
Previous Close	41.56
Day's Range	40.85 - 42.49
52-Week Range	35.23 - 83.83
Beta	0.34
Analysts	Buy
Price Target	59.16 (+40.86%)
Earnings Date	Aug 26, 2026

About SHA:688050

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company provides intraocular lens, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also offers solutions for ophthalmic surgery, refractive error correction, and optometry consumption. The company was founded in 2010 and is headquartered in Beijing, China. [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2010

Employees 2,331

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688050

Full Company Profile

Financial Performance

In 2025, SHA:688050's revenue was 1.48 billion, an increase of 5.15% compared to the previous year's 1.41 billion. Earnings were 268.17 million, a decrease of -30.96%.

Financial Statements

Analyst Summary

According to 6 analysts, the average rating for 688050 stock is "Buy." The 12-month stock price target is ¥59.16, which is an increase of 40.86% from the latest price.

Price Target

¥59.16

(40.86% upside)

Analyst Consensus: Buy

Stock Forecasts